Brief: Seastar Medical Expands Neutralize-Aki Pivotal Trial
08/10/2024 13:39
Oct 8 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* SEASTAR MEDICAL EXPANDS NEUTRALIZE-AKI PIVOTAL TRIAL
ADDING TWO
PREMIER MILITARY MEDICAL FACILITIES
Source text for Eikon: ID:nGNX4vYrvb
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview